Tandem Diabetes earnings on deck as pharmacy shift tests execution
Tandem Diabetes Care Inc. is preparing to announce its second-quarter results, with analysts expecting a loss of 33 cents per share on revenue of $255.1 million. Investors are keenly focused on the company's transition from a traditional durable medical equipment model to a pay-as-you-go …